Suramin in Treating Patients With Recurrent Primary Brain Tumors

Completed · Phase 2

Conditions studied: Brain and Central Nervous System Tumors

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of suramin in treating patients with recurrent primary brain tumors following radiation therapy.

Key facts

Study ID

NCT00002639

Run by

Emory University

Starts

1995-07-01

Expected to finish

2004-05-01

Last updated by the study team

2013-06-21

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Department of Neurosurgery - Emory — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.